🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

My first ⁦IASLC⁩ #WCLC meeting in 2000 Tokyo-Japan. I was a junior thoracic medical oncologist & an investigator. In 2023, with the lung cancer team support, S1929 showed promise to personalize SCLC. Today, I am honored to be nominated #IASLC_Board

🆙NOW #AACR25 #LCSM Abstracts 🔥#CT051 SKYSCRAPER-01: Tiragolumab + atezo vs plac + atezo in 1st Line, PDL1-high, advanced NSCLC 🎙️ Solange Peters 🎯PFS and OS were not met 🎯HR PFS/OS (95%CI) 0.78 (0.63-0.97) / 0.87 (0.71-1.08) 🎯mOS 23.1 vs 16.9 favors Tira OncoAlert AACR

Dr. Nagla Abdel Karim IASLC We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing. oncodaily.com/career/nagla-a…

📍MLS Washington, DC 🎓Updates in Oncology from the Masters 🔬Join us for a cutting-edge Master Lecture Series focused on the latest in immunotherapy, and much more! ✅Registration is Now! - masterlectureseries.com/summary-mls-wa… Dr. Nagla Abdel Karim

Happy Mother’s Day! My flower that I got during my daughter’s volleyball tournament today ❤️

Patterns of progression in #EGFR exon 20 NSCLC on amivantamab Lung Cancer Journal. Lung/pleura most common sites of PD (29%), followed by bone (21 %), brain (15 %) lymph node (12 %). Intracranial only progression uncommon (11%); SRS on ami was safe. lungcancerjournal.info/article/S0169-…

Join us for a Facebook Live on 5/23, with special guest Dr. Nagla Abdel Karim (Inova Schar Cancer Institute) to discuss the application of subtyping and biomarkers for #sclc. Moderated by Misty Dawn Shields (@IU_health) & Ann Fish-Steagall (@lungevity), tune in facebook.com/lungevity @sclcsmashers #lcsm

🚨🔥 #KnowledgeConquersCancer Inviting colleagues ASCO #ASCO25 to: ⭐️An #EducationSession, I’m honored to chair, joined by GREAT EXPERTS: Drs #Rosenstein & #Gosain Oncology Brothers on: ✅The Art & Know-How of #Oncology #Teaching, #Learning & #KnowledgeSharing ⏰Sat, May 31 at

Am honored to be nominated for the IASLC #Board_Of_Directors_2025 Please do not forget to vote.

It was such a great pleasure speaking at SCLC Smashers #Lungevity ⁦Misty Dawn Shields⁩ facebook.com/share/v/1Cq6ED…

A special thank you to our guest Dr. Nagla Karim Dr. Nagla Abdel Karim for a fantastic SmallCellSMASHERS Fireside Chat! We discussed the need for clinical trials including biomarker-driven studies & role of cooperative groups like SWOG Cancer Research Network & Big Ten Cancer Research Consortium to ask important Qs in SCLC! #LCSM

You can listen 🎧 to the episode here: facebook.com/share/v/1Cq6ED…

ASCO and Google Cloud Launch AI-Powered ASCO Guidelines Assistant dailynews.ascopubs.org/do/asco-and-go… @asco #asco25 gilberto lopes

Don’t forget to attend the diverse Community of Practice Groups at the #ASCO2025 annual meeting. The communities are run by ASCO Volunteers, and are an awesome place to connect w like minded individuals, and learn about topics you care about. Plz check out this brilliant line up

Oncology Brothers Kristin Higgins Nathan A. Pennell MD, PhD, FASCO Dr Riyaz Shah gilberto lopes Narjust Florez, MD, FASCO Aakash Desai, MD, MPH, FASCO Alfredo Addeo MD Dr. Amy C. Moore Christian Rolfo Charu Aggarwal, MD, MPH, FASCO Sandip Patel MD FASCO Sanjay Popat Dr. Nagla Abdel Karim Hossein Borghaei, DO Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Hidehito HORINOUCHI Dr. Bosch-Barrera Marina Garassino Tom Newsom-Davis Navneet Singh

So excited to be part of this Phase I Study, the results of which will be presented #ASCO25 #KRAS as an oral presentation.

Just landed and on my way to ⁦ASCO⁩ #ASCO25 Can’t Wait to learn about many updates #LungCancer #SCLC #Developmental_Therapeutics & #AI

We made it to #ASCO25 ⁦ASCO⁩ and running in between sessions & meetings ⁦Ticiana Batista (Leal)⁩ ⁦Mariam Alexander⁩ ⁦Hina Khan⁩ ⁦H. Jack West, MD, FASCO⁩

#AI #ASCO25 Precision Oncology incorporated AI to help enlighten therapeutic options.

#ASCO25 #NewsFlash gilberto lopes Tiffany Stevens 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 ASCO